Role of protein carbonylation in diabetes

Journal of Inherited Metabolic Disease

Volumn 41, Issue 1, 2018, Pages 29-38

  Hecker, Markus ^a   Wagner, Andreas H ^a  

^a UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Methylglyoxal; Post translational modification; Protein carbonylation; Reactive oxygen species; Redox signaling

Indexed keywords

ACROLEIN; ANTIOXIDANT; CARNITINE; GLUTATHIONE PEROXIDASE 1; GLUTATHIONE TRANSFERASE A4; MALONALDEHYDE; PEROXIREDOXIN; PEROXIREDOXIN 1; PEROXIREDOXIN 2; PEROXIREDOXIN 4; PEROXIREDOXIN 6; REACTIVE OXYGEN METABOLITE; SUPEROXIDE DISMUTASE; UBIQUITINATED PROTEIN; ANTIDIABETIC AGENT;

DIABETES MELLITUS; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; METABOLIC REGULATION; NONHUMAN; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN HOMEOSTASIS; PROTEIN MODIFICATION; PROTEIN STRUCTURE; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BLOOD; DRUG EFFECT; ENERGY METABOLISM; METABOLISM;

ANIMALS; ANTIOXIDANTS; BLOOD GLUCOSE; DIABETES MELLITUS; ENERGY METABOLISM; HUMANS; HYPOGLYCEMIC AGENTS; OXIDATIVE STRESS; PROTEIN CARBONYLATION; PROTEOLYSIS; REACTIVE OXYGEN SPECIES;

EID: 85033448807     PISSN: 01418955     EISSN: 15732665     Source Type: Journal    
DOI: 10.1007/s10545-017-0104-9     Document Type: Review

References (84)

1. Abbasi A, Corpeleijn E, Gansevoort RT et al (2014) Circulating peroxiredoxin 4 and type 2 diabetes risk: the prevention of renal and vascular endstage disease (PREVEND) study. Diabetologia 57:1842–1849
2. Adams S, Green P, Claxton R et al (2001) Reactive carbonyl formation by oxidative and non-oxidative pathways. Front Biosci 6:A17–A24
3. Aiken CT, Kaake RM, Wang X, Huang L (2011) Oxidative stress-mediated regulation of proteasome complexes. Mol Cell Proteomics 10:R110 006924
4. Al-Khalili L, de Castro Barbosa T, Ostling J et al (2014) Proteasome inhibition in skeletal muscle cells unmasks metabolic derangements in type 2 diabetes. Am J Physiol Cell Physiol 307: C774-C787
5. Albrecht T, Schilperoort M, Zhang S et al (2017) Carnosine attenuates the development of both type 2 diabetes and diabetic nephropathy in BTBR ob/ob mice. Sci Rep 7:44492
6. American Diabetes Association (2016) 6. Obesity management for the treatment of type 2 diabetes. Diabetes Care 39(Suppl 1):S47–S51
7. Bollineni RC, Fedorova M, Bluher M, Hoffmann R (2014) Carbonylated plasma proteins as potential biomarkers of obesity induced type 2 diabetes mellitus. J Proteome Res 13:5081–5093
8. Bugger H, Abel ED (2008) Molecular mechanisms for myocardial mitochondrial dysfunction in the metabolic syndrome. Clin Sci (Lond) 114:195–210
9. Bugger H, Abel ED (2014) Molecular mechanisms of diabetic cardiomyopathy. Diabetologia 57:660–671
10. Cade WT (2008) Diabetes-related microvascular and macrovascular diseases in the physical therapy setting. Phys Ther 88:1322–1335
11. Carballal S, Cuevasanta E, Marmisolle I et al (2013) Kinetics of reversible reductive carbonylation of heme in human cystathionine beta-synthase. Biochemistry 52:4553–4562
12. Cardellini M, Menghini R, Martelli E et al (2009) TIMP3 is reduced in atherosclerotic plaques from subjects with type 2 diabetes and increased by SirT1. Diabetes 58:2396–2401
13. Casagrande V, Menghini R, Menini S et al (2012) Overexpression of tissue inhibitor of metalloproteinase 3 in macrophages reduces atherosclerosis in low-density lipoprotein receptor knockout mice. Arterioscler Thromb Vasc Biol 32:74–81
14. Castro JP, Jung T, Grune T, Siems W (2017) 4-Hydroxynonenal (HNE) modified proteins in metabolic diseases. Free Radic Biol Med 111:309–315
15. Cattaruzza M, Hecker M (2008) Protein carbonylation and decarboylation: a new twist to the complex response of vascular cells to oxidative stress. Circ Res 102:273–274
16. Chait A, Bornfeldt KE (2009) Diabetes and atherosclerosis: is there a role for hyperglycemia? J Lipid Res 50(Suppl):S335–S339
17. Chawla A, Chawla R, Jaggi S (2016) Microvasular and macrovascular complications in diabetes mellitus: distinct or continuum? Indian J Endocrinol Metab 20:546–551
18. Chen M, Curtis TM, Stitt AW (2013) Advanced glycation end products and diabetic retinopathy. Curr Med Chem 20:3234–3240
19. Chung SS, Ho EC, Lam KS, Chung SK (2003) Contribution of polyol pathway to diabetes-induced oxidative stress. J Am Soc Nephrol 14:S233–S236
20. Curtis JM, Grimsrud PA, Wright WS et al (2010) Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes 59:1132–1142
21. Curtis JM, Hahn WS, Long EK, Burrill JS, Arriaga EA, Bernlohr DA (2012) Protein carbonylation and metabolic control systems. Trends Endocrinol Metab 23:399–406
22. de Haan JB (2011) Nrf2 activators as attractive therapeutics for diabetic nephropathy. Diabetes 60:2683–2684
23. Diaz-Villanueva JF, Diaz-Molina R, Garcia-Gonzalez V (2015) Protein folding and mechanisms of proteostasis. Int J Mol Sci 16:17193–17230
24. Dos Santos Mello M, Ribas GS, Wayhs CA et al (2015) Increased oxidative stress in patients with 3-hydroxy-3-methylglutaric aciduria. Mol Cell Biochem 402:149–155
25. El Eter E, Al-Masri AA (2015) Peroxiredoxin isoforms are associated with cardiovascular risk factors in type 2 diabetes mellitus. Braz J Med Biol Res 48:465–469
26. Fedorova M, Bollineni RC, Hoffmann R (2014) Protein carbonylation as a major hallmark of oxidative damage: update of analytical strategies. Mass Spectrom Rev 33:79–97
27. Fernandes CG, da Rosa MS, Seminotti B et al (2013) In vivo experimental evidence that the major metabolites accumulating in 3-hydroxy-3-methylglutaryl-CoA lyase deficiency induce oxidative stress in striatum of developing rats: a potential pathophysiological mechanism of striatal damage in this disorder. Mol Genet Metab 109: 144-153
28. Fisher AB (2009) Redox signaling across cell membranes. Antioxid Redox Signal 11:1349–1356
29. Frohnert BI, Bernlohr DA (2013) Protein carbonylation, mitochondrial dysfunction, and insulin resistance. Adv Nutr 4:157–163
30. Gajjala PR, Fliser D, Speer T, Jankowski V, Jankowski J (2015) Emerging role of post-translational modifications in chronic kidney disease and cardiovascular disease. Nephrol Dial Transplant 30:1814–1824
31. Giacco F, Brownlee M (2010) Oxidative stress and diabetic complications. Circ Res 107:1058–1070
32. Grimsrud PA, Picklo MJ Sr, Griffin TJ, Bernlohr DA (2007) Carbonylation of adipose proteins in obesity and insulin resistance: identification of adipocyte fatty acid-binding protein as a cellular target of 4-hydroxynonenal. Mol Cell Proteomics 6:624–637
33. Grimsrud PA, Xie H, Griffin TJ, Bernlohr DA (2008) Oxidative stress and covalent modification of protein with bioactive aldehydes. J Biol Chem 283:21837–21841
34. Hasanain B, Mooradian AD (2002) Antioxidant vitamins and their influence in diabetes mellitus. Curr Diab Rep 2:448–456
35. Higdon A, Diers AR, Oh JY, Landar A, Darley-Usmar VM (2012) Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochem J 442:453–464
36. Irani DN (2017) Cerebrospinal fluid protein carbonylation identifies oxidative damage in autoimmune demyelination. Ann Clin Transl Neurol 4:145–150
37. Jung T, Grune T (2008) The proteasome and its role in the degradation of oxidized proteins. IUBMB Life 60:743–752
38. Kender Z, Fleming T, Kopf S et al (2014) Effect of metformin on methylglyoxal metabolism in patients with type 2 diabetes. Exp Clin Endocrinol Diabetes 122:316–319
39. Kong X, Ma MZ, Huang K et al (2014) Increased plasma levels of the methylglyoxal in patients with newly diagnosed type 2 diabetes 2. J Diabetes 6:535–540
40. Konig A, Bode C, Bugger H (2012) Diabetes mellitus and myocardial mitochondrial dysfunction: bench to bedside. Heart Fail Clin 8:551–561
41. Konstantopoulos N, Foletta VC, Segal DH et al (2011) A gene expression signature for insulin resistance. Physiol Genomics 43:110–120
42. Kostidou E, Koliakos G, Alamdari DH, Paletas K, Tsapas A, Kaloyianni M (2007) Enhanced laminin carbonylation by monocytes in diabetes mellitus. Clin Biochem 40:671–679
43. Kostidou E, Topouridou K, Daniilidis A, Kaloyianni M, Koliakos G (2009) Oxidized laminin-1 induces increased monocyte attachment and expression of ICAM-1 in endothelial cells. Int J Exp Pathol 90:630–637
44. Lee I, Suzuki CK (2008) Functional mechanics of the ATP-dependent Lon protease- lessons from endogenous protein and synthetic peptide substrates. Biochim Biophys Acta 1784:727–735
45. Lei XG, Vatamaniuk M (2016) Glutathione Peroxidase 1: models for diabetes and obesity. In Hatfield DL, Schweizer U, Tsuji PA, Gladyshev VN eds. Selenium: Its Molecular Biology and Role in Human Health. Cham: Springer, pp 587-594
46. Loukovaara S, Koivunen P, Ingles M, Escobar J, Vento M, Andersson S (2014) Elevated protein carbonyl and HIF-1alpha levels in eyes with proliferative diabetic retinopathy. Acta Ophthalmol 92:323–327
47. Lu J, Holmgren A (2014) The thioredoxin antioxidant system. Free Radic Biol Med 66:75–87
48. Maessen DE, Stehouwer CD, Schalkwijk CG (2015) The role of methylglyoxal and the glyoxalase system in diabetes and other age-related diseases. Clin Sci (Lond) 128:839–861
49. Maisonneuve E, Ducret A, Khoueiry P et al (2009) Rules governing selective protein carbonylation. PLoS One 4:e7269
50. Margetis PI, Antonelou MH, Petropoulos IK, Margaritis LH, Papassideri IS (2009) Increased protein carbonylation of red blood cell membrane in diabetic retinopathy. Exp Mol Pathol 87:76–82
51. Mc Guire PJ, Parikh A, Diaz GA (2009) Profiling of oxidative stress in patients with inborn errors of metabolism. Mol Genet Metab 98:173–180
52. McClung JP, Roneker CA, Mu W et al (2004) Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase. Proc Natl Acad Sci U S A 101:8852–8857
53. Nikiforova VJ, Giesbertz P, Wiemer J et al (2014) Glyoxylate, a new marker metabolite of type 2 diabetes. J Diabetes Res 2014:685204
54. Nishikawa T, Araki E (2013) Mechanism-based antioxidant therapies promise to prevent diabetic complications? J Diabetes Investig 4:105–107
55. Nystrom T (2005) Role of oxidative carbonylation in protein quality control and senescence. EMBO J 24:1311–1317
56. Oya T, Hattori N, Mizuno Y et al (1999) Methylglyoxal modification of protein. Chemical and immunochemical characterization of methylglyoxal-arginine adducts. J Biol Chem 274:18492–18502
57. Pacifici F, Arriga R, Sorice GP et al (2014) Peroxiredoxin 6, a novel player in the pathogenesis of diabetes. Diabetes 63:3210–3220
58. Pavone B, Sirolli V, Giardinelli A et al (2011) Plasma protein carbonylation in chronic uremia. J Nephrol 24:453–464
59. Peters V, Lanthaler B, Amberger A et al (2015) Carnosine metabolism in diabetes is altered by reactive metabolites. Amino Acids 47:2367–2376
60. Poynton RA, Hampton MB (2014) Peroxiredoxins as biomarkers of oxidative stress. Biochim Biophys Acta 1840:906–912
61. Queisser MA, Yao D, Geisler S et al (2010) Hyperglycemia impairs proteasome function by methylglyoxal. Diabetes 59:670–678
62. Rabbani N, Thornalley PJ (2014) The critical role of methylglyoxal and glyoxalase 1 in diabetic nephropathy. Diabetes 63:50–52
63. Randolph GJ (2009) The fate of monocytes in atherosclerosis. J Thromb Haemost 7(Suppl 1):28–30
64. Ribas GS, Vargas CR, Wajner M (2014) L-carnitine supplementation as a potential antioxidant therapy for inherited neurometabolic disorders. Gene 533:469–476
65. Ristoff E, Larsson A (2002) Oxidative stress in inborn errors of metabolism: lessons from glutathione deficiency. J Inherit Metab Dis 25:223–226
66. Ruskovska T, Bernlohr DA (2013) Oxidative stress and protein carbonylation in adipose tissue—implications for insulin resistance and diabetes mellitus. J Proteome 92:323–334
67. Shah A, Xia L, Goldberg H, Lee KW, Quaggin SE, Fantus IG (2013) Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells. J Biol Chem 288:6835–6848
68. Shah PT, Martin R, Yan Y, Shapiro JI, Liu J (2016) Carbonylation modification regulates Na/K-ATPase Signaling and salt sensitivity: a review and a hypothesis. Front Physiol 7:256
69. Sharma M, Gupta S, Singh K et al (2016) Association of glutathione-S-transferase with patients of type 2 diabetes mellitus with and without nephropathy. Diabetes Metab Syndr 10:194–197
70. Simmons RK, Echouffo-Tcheugui JB, Sharp SJ et al (2012) Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial. Lancet 380:1741–1748
71. Singhal SS, Singh SP, Singhal P, Horne D, Singhal J, Awasthi S (2015) Antioxidant role of glutathione S-transferases: 4-Hydroxynonenal, a key molecule in stress-mediated signaling. Toxicol Appl Pharmacol 289:361–370
72. Stanton RC (2012) Glucose-6-phosphate dehydrogenase, NADPH, and cell survival. IUBMB Life 64:362–369
73. Suravajjala S, Cohenford M, Frost LR, Pampati PK, Dain JA (2013) Glycation of human erythrocyte glutathione peroxidase: effect on the physical and kinetic properties. Clin Chim Acta 421:170–176
74. Sykiotis GP, Bohmann D (2008) Keap1/Nrf2 signaling regulates oxidative stress tolerance and lifespan in drosophila. Dev Cell 14:76–85
75. Tesauro M, Nistico S, Noce A et al (2015) The possible role of glutathione-S-transferase activity in diabetic nephropathy. Int J Immunopathol Pharmacol 28:129–133
76. Thornalley PJ (2008) Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems—role in ageing and disease. Drug Metabol Drug Interact 23:125–150
77. Turpaev KT (2013) Keap1-Nrf2 signaling pathway: mechanisms of regulation and role in protection of cells against toxicity caused by xenobiotics and electrophiles. Biochemistry (Mosc) 78:111–126
78. Van’t Riet E, Alssema M, Rijkelijkhuizen JM, Kostense PJ, Nijpels G, Dekker JM (2010) Relationship between A1C and glucose levels in the general Dutch population: the new Hoorn study. Diabetes Care 33:61–66
79. Vanzin CS, Biancini GB, Sitta A et al (2011) Experimental evidence of oxidative stress in plasma of homocystinuric patients: a possible role for homocysteine. Mol Genet Metab 104:112–117
80. Vanzin CS, Mescka CP, Donida B et al (2015) Lipid, oxidative and inflammatory profile and alterations in the enzymes paraoxonase and butyrylcholinesterase in plasma of patients with homocystinuria due CBS deficiency: the vitamin B12 and folic acid importance. Cell Mol Neurobiol 35:899–911
81. Wong CM, Bansal G, Marcocci L, Suzuki YJ (2012) Proposed role of primary protein carbonylation in cell signaling. Redox Rep 17:90–94
82. Wong CM, Cheema AK, Zhang L, Suzuki YJ (2008) Protein carbonylation as a novel mechanism in redox signaling. Circ Res 102:310–318
83. Wong CM, Marcocci L, Das D et al (2013) Mechanism of protein decarbonylation. Free Radic Biol Med 65:1126–1133
84. Zatalia SR, Sanusi H (2013) The role of antioxidants in the pathophysiology, complications, and management of diabetes mellitus. Acta Med Indones 45:141–147